| 000 | 01748 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515120525.0 | ||
| 264 | 0 | _c20081002 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a0166-3542 | ||
| 024 | 7 |
_a10.1016/j.antiviral.2008.03.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSu, Ching-Yao | |
| 245 | 0 | 0 |
_aIn vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses. _h[electronic resource] |
| 260 |
_bAntiviral research _cSep 2008 |
||
| 300 |
_a199-205 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGenes, Reporter _xdrug effects |
| 650 | 0 | 4 | _aGenetic Engineering |
| 650 | 0 | 4 |
_aHemagglutinins, Viral _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza, Human _xdrug therapy |
| 650 | 0 | 4 |
_aLeukemia Virus, Murine _xgenetics |
| 650 | 0 | 4 |
_aNeuraminidase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOrthomyxoviridae _xdrug effects |
| 650 | 0 | 4 |
_aOseltamivir _xpharmacology |
| 650 | 0 | 4 |
_aVirus Shedding _xdrug effects |
| 650 | 0 | 4 |
_aZanamivir _xpharmacology |
| 700 | 1 | _aWang, Shi-Yun | |
| 700 | 1 | _aShie, Jiun-Jie | |
| 700 | 1 | _aJeng, King-Song | |
| 700 | 1 | _aTemperton, Nigel J | |
| 700 | 1 | _aFang, Jim-Min | |
| 700 | 1 | _aWong, Chi-Huey | |
| 700 | 1 | _aCheng, Yih-Shyun E | |
| 773 | 0 |
_tAntiviral research _gvol. 79 _gno. 3 _gp. 199-205 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.antiviral.2008.03.002 _zAvailable from publisher's website |
| 999 |
_c17949018 _d17949018 |
||